The narcolepsy treatment market is projected to grow from USD 5,301.6 million in 2024 to USD 8,718.3 million by 2034, at a ...

The world’s largest genetic study into depression has uncovered life-changing discoveries that will revolutionise treatments ...

The FDA has expanded the approval of Lumryz (sodium oxybate) extended-release oral suspension to include treatment of pediatric narcolepsy.

Avadel Pharmaceuticals expects its narcolepsy treatment Lumryz to drive strong revenue growth in the fourth quarter and into 2025, preliminary earnings show.

Avadel’s commercial product, LUMRYZ, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or EDS in both adults and ...

Combining Adderall with other CNS stimulants, such as caffeine, can increase the risk of side effects, including elevated ...

A total of six out of the 98 drivers and conductors were tested positive for illegal drug use during the conduct of surprise drug tests as part of the road safety measures for the Holiday season, the ...

While these medications are used to reduce pain, inflammation, and fever, over time they can cause changes to the blood that raise the chances of heart attacks and strokes. If taken in high doses ...

Semaglutide was first created as a diabetes drug, but because of its appetite-suppressing properties, it has been used more frequently recently. Kennedy stated that there's a huge push to sell this to ...

A narcolepsy service dog can warn you that an episode is coming, wake you afterward, get help if you’re hurt, and fetch medications and ... We only use quality, credible sources to ensure ...

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...

2024 brought some major advancements in medicine. That includes the approval of "innovative" drugs like Tryvio for high blood pressure, Neffy for severe allergic reactions and Dupixent for chronic ...